Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Ophthalmology ; 106(12): 2286-90, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10599658

ABSTRACT

OBJECTIVE: To investigate the penetration of levofloxacin, an optical S-(-)isomer of ofloxacin, into the aqueous and vitreous humor after oral administration. DESIGN: Randomized, clinical trial comparing tissue levels of levofloxacin after one or two doses 12 hours apart. PARTICIPANTS: Forty-five patients undergoing initial vitrectomy between February 1997 and June 1997 at the UIC Eye Center. METHODS: Aqueous, vitreous, and serum samples were obtained and later analyzed from 45 patients after oral administration of 1 500-mg tablet (group 1, 22 patients) or 2 500-mg tablets (group 2, 23 patients) 12 hours apart before surgery. MAIN OUTCOME MEASURES: Aqueous, vitreous, and serum concentrations of levofloxacin (micrograms/milliliter). RESULTS: Group 1 achieved mean aqueous, vitreous, and serum levels of 0.59 +/- 0.48 microg/ml, 0.32 +/- 0.34 microg/ml, and 4.34 +/- 3.59 microg/ml, respectively. Group 2 achieved mean aqueous, vitreous, and serum levels of 1.90 +/- 0.97 microg/ml, 2.39 +/- 0.70 microg/ml, and 8.02 +/- 3.14 microg/ml. CONCLUSIONS: Mean inhibitory aqueous and vitreous MIC90 levels were achieved against a majority of ocular pathogens, including Staphylococcus aureus and Staphylococcus epidermidis, Streptococcus pneumoniae (vitreous), Bacillus cereus (vitreous), Haemophilus influenzae, Moraxella catarrhalis, and most gram-negative aerobic organisms except Pseudomonas aeruginosa after two doses given 12 hours apart. Mean MIC90 levels were obtained in the vitreous for a majority of pathogens responsible for traumatic, postoperative, or bleb-related endophthalmitis.


Subject(s)
Anti-Infective Agents/pharmacokinetics , Aqueous Humor/metabolism , Levofloxacin , Ofloxacin/pharmacokinetics , Vitreous Body/metabolism , Administration, Oral , Anti-Infective Agents/administration & dosage , Anti-Infective Agents/pharmacology , Bacteria/drug effects , Biological Availability , Female , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Ofloxacin/administration & dosage , Tablets , Tissue Distribution , Vitrectomy
4.
Biotechniques ; 6(6): 526-30, 1988 Jun.
Article in English | MEDLINE | ID: mdl-3273185

ABSTRACT

We describe a simple, flexible, rapid, sensitive and accurate in vivo assay of the bacterial chloramphenicol acetyltransferase (CAT) enzyme expressed in mammalian cells. The assay is based on the ability of the substrate and products of this enzyme reaction (viz. chloramphenicol and its acetylated derivatives) to equilibrate rapidly between the cells and the surrounding tissue culture medium. We find that chloramphenicol added to the culture medium readily enters the cells and becomes acetylated by the intracellular CAT enzyme. The acetyl derivatives leave the cell and appear rapidly in the culture medium. Due to the large excess of the extracellular compared to the intracellular fluid and due to rapid equilibration of chloramphenicol and its derivatives between them, we find that the bulk of the chloramphenicol and its acetyl derivatives are present in the culture medium at any given time point. Chloramphenicol and its acetylated products are extracted from the medium with ethyl acetate and resolved by thin layer chromatography giving an accurate measurement of the intracellular CAT activity. Sensitive and accurate quantitation of CAT activity in this assay is made possible by the addition of trace amounts of 14C-labeled chloramphenicol to the medium.


Subject(s)
Chloramphenicol O-Acetyltransferase/analysis , Animals , Biotechnology , Cell Line , Chloramphenicol/metabolism , Chloramphenicol O-Acetyltransferase/genetics , Chloramphenicol O-Acetyltransferase/metabolism , Gene Expression Regulation, Enzymologic , Plasmids
SELECTION OF CITATIONS
SEARCH DETAIL
...